Scanlan Sean F. 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Jul 22, 2025
Insider Transaction Report
Form 4
Scanlan Sean F.
Chief Innovation Officer
Transactions
- Exercise/Conversion
Common Stock
2025-07-18$0.72/sh+33,437$24,001→ 383,621 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-07-18−33,437→ 0 totalExercise: $0.72From: 2019-07-28Exp: 2025-07-28→ Common Stock (33,437 underlying)
Footnotes (3)
- [F1]Includes 325,098 restricted stock units.
- [F2]Reflects the transfer of 13,897 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.
- [F3]The stock option vested in equal annual installments over 4 years, commencing on July 28, 2015 with the last installment vesting on July 28, 2019.